menu
    • menu
    [{"orgOrder":0,"company":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","sponsor":"Biofortis M\u00e9rieux Nutriscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Dihydroberberine","moa":"AMPK pathway|mitochondrial complex I","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nanjing Nutrabuilding Bio-tech Co., Ltd. \/ Biofortis M\u00e9rieux Nutriscience","highestDevelopmentStatusID":"1","companyTruncated":"Nanjing Nutrabuilding Bio-tech Co., Ltd. \/ Biofortis M\u00e9rieux Nutriscience"},{"orgOrder":0,"company":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","sponsor":"M\u00e9rieux NutriSciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CHINA","productType":"Dietary Supplement","year":"2026","type":"Inapplicable","leadProduct":"Dihydroberberine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Nanjing Nutrabuilding Bio-tech Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nanjing Nutrabuilding Bio-tech Co., Ltd. \/ M\u00e9rieux Nutriscience","highestDevelopmentStatusID":"1","companyTruncated":"Nanjing Nutrabuilding Bio-tech Co., Ltd. \/ M\u00e9rieux Nutriscience"}]

    Find Clinical Drug Pipeline Developments & Deals for Dihydroberberine

    Menu

    Dihydroberberine

    DEVELOPMENTS

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Nanjing Nutrabuilding Bio-tech Co., Ltd.

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Nanjing Nutrabuilding Bio-tech Co., Ltd.

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dihydroberberine,Microcrystalline Cellulose

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Mérieux NutriSciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults

                            Details : Dihydroberberine is a Dietary Supplement drug, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            January 07, 2026

                            Lead Product(s) : Dihydroberberine,Microcrystalline Cellulose

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Mérieux NutriSciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Nanjing Nutrabuilding Bio-tech Co., Ltd.

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Nanjing Nutrabuilding Bio-tech Co., Ltd.

                            Country arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Dihydroberberine

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Biofortis Mérieux Nutriscience

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

                            Details : Dihydroberberine is a small molecule drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Prediabetic State.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            October 07, 2025

                            Lead Product(s) : Dihydroberberine

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Biofortis Mérieux Nutriscience

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.